Advertisement

Inhibition of Malignant Tumor Cell Invasion: An Approach to Anti-Progression

  • Adriana Albini
  • Annamaria Colacci
Part of the Basic Life Sciences book series (BLSC, volume 61)

Abstract

Considerable attention should be given to primary prevention of neoplastic transformation. The best approaches to anticarcinogenesis are preventative measures to reduce exposure to environmental pollutants and improving life styles that may be responsible for genetic and epigenetic cell damage. Once neoplastic transformation has occurred, however, the major target of the oncologist becomes hindering tumor progression. It is difficult to define the onset of tumor progression and whether it involves a continous evolution or a step-like process. It is easier to define the consequence of tumor progression: malignant lesions with the ability to invade and to metastasize to distant organs. While benign tumors can often be cured simply by surgical removal, metastases remain the most frequent cause of cancer mortality.

Keywords

Basement Membrane Melanoma Cell Metastatic Tumor Cell Experimental Metastasis Laminin Receptor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Albelda, S.M., and C.A. Buck (1990) lntegrins and other cell adhesion molecules. FASEB J. 4:2868–2880.PubMedGoogle Scholar
  2. 2.
    Albini, A., B. Adelmann-Grill, and P.K. Muller (1985) Fibroblast chemotaxis. Collagen Rel. Res. 5:283–296.CrossRefGoogle Scholar
  3. 3.
    Albini, A., G. Allavena, A. Melchiori, F. Giancotti, H. Richter, G.R. Martin, and G. Tarone (1987) Chemotaxis of 3T3 and SV3T3 cells to fibronectin is mediated through the cell attachment site in fibronectin and a fibronectin cell surface receptor. J. Cell. Biol. 105:1867–1872.PubMedCrossRefGoogle Scholar
  4. 4.
    Albini, A, S.L. Aukerman, D.M. Noonan, R.C. Ogle, R. Fridman, G.R. Martin, and I.J. Fidler (1989) The in vitro invasiveness and interactions with laminin of K-1735 melanoma cells. J. Clin. Exp. Met. 7:437–451.CrossRefGoogle Scholar
  5. 5.
    Albini, A., Y. Iwamoto, H.K. Kleinman, G.R. Martin, S.A. Aaronson, J.M. Kozlowski, and R.N. McEwan (1987) A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47:3239–3245.PubMedGoogle Scholar
  6. 6.
    Albini, A., A. Melchiori, S. Parodi, L. Santi, LA. Liotta, and W.G. Stetler-Stevenson (1990) TIMP-2 and synthetic peptides derived from the profragment of collagenase type IV inhibit invasion in the “chemoinvasion assay.” Clin. Exper. Metastasis. 8 suppl 1:66.Google Scholar
  7. 7.
    Albini, A., A. Melchiori, L. Santi, L.A Liotta, P. Brown, and W.G. Stetler-Stevenson (1991) Tumor cell invasion inhibited by TIMP-2. J. Natl. Cancer Inst. 83:775–779.PubMedCrossRefGoogle Scholar
  8. 8.
    Allavena, G., A. Melchiori, O. Aresu, L. Ferreri-Santi, R. McEwan, G. Kitten, S. Parodi, and A. Albini (1988) In vitro models for studying the malignant phenotype: Chemotaxis and chemoinvasion. In Cancer Metastasis. Biological and Biochemical Mechanisms and Clinical Aspects. G. Prodi, L.A. Liotta, P.L. Lollini, S. Garbisa, S. Gorini, and K. Hellman, eds. Plenum Press, New York, pp. 215–226.Google Scholar
  9. 9.
    Bonfil, R., S. Momiki, C. Conti, and A. Klein-Szanto (1989) Benzoyl peroxide enhances the invasive ability of a mouse epidermal carcinoma cell line. Int. J. Cancer 44:165–169.PubMedCrossRefGoogle Scholar
  10. 10.
    Bonfil, R., S. Momiki, R. Fridman, R. Reich, R. Reddel, C. Harris, and A. Klein Szanto (1989) Enhancement of the invasive ability of a transformed human bronchial epithelial cell line by 12-0-tetradecanoyl-phorbol-13-acetate and diacylglycerol. Carcinogenesis 10:2335–2338.PubMedCrossRefGoogle Scholar
  11. 11.
    Briozzo, P., M. Morisset, F. Capony, C. Rougeot, and H. Rochefort (1988) In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells. Cancer Res. 48:3688–3692.PubMedGoogle Scholar
  12. 12.
    Chua, C.C., D.E. Geiman, G.H. Keller, and R.L. Ladda (1985) Induction of collagenase secretion in human fibroblast cultures by growth promoting, factors. J. Biol. Chem. 260:5213–5216.PubMedGoogle Scholar
  13. 13.
    Colacci, A., A. Albini. A. Melchiori, P. Nanni, G. Nicoletti, S. Parodi, N. Bobola, and S. Grilli (1992) Role of chlorocompounds in multistep carcinogenesis: Acquisition of tumorigenic, metastatic and invasive potential by BALB/c 3T3 cells treated with 1,1,2,2-tetrachloroethane. Int. J. Cancer (Submitted)Google Scholar
  14. 14.
    DeClerk, Y.A., T.D. Yean, D. Chan, H. Shimada, and K.E. Langley (1991) Inhibition of tumor invasion of smooth muscle cell layers by recombinant human metalloproteinase inhibitor. Cancer Res. 51:2151–2157.Google Scholar
  15. 15.
    Dedhar, S., and R. Saulnier (1990) Alterations in integrin receptor expression on chemically transformed human cells: Specific enhancement of laminin and collagen receptor complexes. J. Cell Biol. 110:481–489.PubMedCrossRefGoogle Scholar
  16. 16.
    Erkell, L.J., and V. Schirrmacher (1988) Quantitative in-vitro assay for tumor cell invasion through extracellular matrix or into protein gels. Cancer Res. 48:6933–6937.PubMedGoogle Scholar
  17. 17.
    Fidler, I.J. (1990) Critical factors in the biology of human cancer metastases: 28th G.H. Clowes Memorial Award Lecture. Cancer Res. 50:613–618.Google Scholar
  18. 18.
    Fidler, I.J. (1991) Orthotopic implantation of human colon carcinoma into nude mice provides a valuable model for the biology and therapy of metastasis. Cancer Met. Rev. 10:229–243.CrossRefGoogle Scholar
  19. 19.
    Fidler, I.J., S. Naito, and S. Pathak (1990) Orthotopic implantation is essential for the selection, growth and metastasis of human renal cell cancer in nude mice. Cancer Metas. Rev. 9:149–165.CrossRefGoogle Scholar
  20. 20.
    Folkman, J., and M. Klagsbrun (1987) Angiogenic factors. Science 235:442–447.PubMedCrossRefGoogle Scholar
  21. 21.
    Fridman, R., J. Lacal, R. Reich, D. Bonfil, and C. Ahn (1990) Differential effects of phorbol ester on the in vitro invasiveness of malignant and non-malignant human fibroblast cells. J. Cell Phvsiol. 142:55–60.CrossRefGoogle Scholar
  22. 22.
    Gambari, R., R. Barbieri, G. Feriotto, D. Spandidos, and C. Nastruzzi (1990) Effects of the proteinase inhibitor tetra-p-amidino-phenoxy-neopentane on in vitro adhesion and invasiveness of tumor cells. Anticancer Res. 10:259–263.PubMedGoogle Scholar
  23. 23.
    Gehlsen, K.R., W.S. Argraves, M.D. Pierschbacher, and E. Ruoslahti (1988) Inhibition of in vitro tumor cell invasion by Arg-Gly-Asp-containing synthetic peptides. J. Cell Biol. 106:925–930.PubMedCrossRefGoogle Scholar
  24. 24.
    Gehlsen, K.R., L. Dillner, E. Engvall, and E. Ruoslahti (1988) The human laminin receptor is a member of the integrin family of cell adhesion receptors. Science 241:1228–1229.PubMedCrossRefGoogle Scholar
  25. 25.
    Giavazzi, R. (1991) The nude mouse in oncology research. In Metastatic Models, E. Boven and B. Winograd, eds. CRC Press, Inc., London, pp. 117–132.Google Scholar
  26. 26.
    Giavazzi, R., J.M. Jessup, D.E. Campbell, S.M. Walker, and I.J.F. Fidler (1986) Experimental nude mouse model of human colorectal cancer liver metastases. J. Natl. Cancer Inst. 77:1303–1308.PubMedGoogle Scholar
  27. 27.
    Goldberg, G.I., B.L. Marmer, G.A. Grant, A.Z. Eisen, S. Wilhelm, and C. He (1989) Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc. Natl. Acad. Sci., USA 86:8207–8211.PubMedCrossRefGoogle Scholar
  28. 28.
    Graf, J., R.C. Ogle, F.A. Robey, M. Sasaki, G.R. Martin, Y. Yamada, and H.K. Kleinman (1987) A pentapetide from the laminin B1 chain mediates cell adhesion and binds the 67 000 laminin receptor. Biochem. 26:6896–6900.CrossRefGoogle Scholar
  29. 29.
    Grant, D.S., C.P. Leblond, H.K. Kleinman, S. Inoue, and J.R. Hassel (1989) The incubation of laminin, collagen IV and heparin sulfate proteoglycan at 35°C yields basement-membrane-like structures. J. Cell Biol. 108:1567–1574.PubMedCrossRefGoogle Scholar
  30. 30.
    Hart, I.R., and I.J. Fidler (1978) An in vitro quantitative assay for tumor cell invasion. Cancer Res. 38:3218–3224.PubMedGoogle Scholar
  31. 31.
    Hoyhtya, M., E. Hujanen, T. Turpeenniemi-Hujanen, U. Thorgeirsson, L. Liotta, and K. Tryggvason (1990) Modulation of type-lV collagenase activity and invasive behavior of metastatic human melanoma (A2058) cells in vitro by monoclonal antibodies to type-lV collagenase. Int. J. Cancer 46:282–286.PubMedCrossRefGoogle Scholar
  32. 32.
    Humphries, M., Y. Yasuda, K. Olden, and K. Yamada (1988) The cell interaction sites of fibronectin in tumour metastasis. Ciba Found. Symp. 141:75–93.PubMedGoogle Scholar
  33. 33.
    Iwamoto, Y., F.A. Robey, J. Graf, M. Sasaki, H.K. Kleinman, Y. Yamada, and G.R. Martin (1987) YIGSR, a synthetic laminin pentapeptide, inhibits experimental metastasis formation. Science 238:1132–1134.PubMedCrossRefGoogle Scholar
  34. 34.
    Kanemoto, T., R. Reich, L. Royce, D. Greatorex, S.H. Adler, N. Shiraishi, G.R. Martin, Y. Yamada and H.K. Kleinman (1990) Identification of an amino acid sequence from the laminin A chain that stimulates metastasis and collagenase IV production. Proc. Natl. Acad. Sci., USA 87:2279–2283.PubMedCrossRefGoogle Scholar
  35. 35.
    Khokha, R., P. Waterhouse, S. Yagel, P.K. Lala, C.M. Overall, G. Norton, and D.T. Denhardt (1989) Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science 243:947–950.PubMedCrossRefGoogle Scholar
  36. 36.
    Kleinman, H.K., F.B. Cannon, G.W. Laurie, J.R. Hassel, M. Aumailley, V.P. Terranova, G.R. Martin, and M. Dubois-Dalcq (1985) Biological activities of laminin. J Cell Biochem. 27:317.PubMedCrossRefGoogle Scholar
  37. 37.
    Kleinman, H.K., J. Graf, Y. Iwamoto, G. Kitten, R. Ogle, M. Sasaki, Y. Yamada, G.R. Martin, and L. Luckenbill-Edds (1987) Role of basement membranes in cell differentiation. Ann. N.Y. Acad. Sci. 513:134–145.PubMedCrossRefGoogle Scholar
  38. 38.
    Kleinman, H.K., M.L. McGarvey, J.R. Hassell, V.L. Star, F. Cannon, G.W. Laurie, and G.R. Martin (1986) Basement membranes complexes with biological activity. Biochemistry 25:312–318.PubMedCrossRefGoogle Scholar
  39. 39.
    Kohn, E., M. Stracke, C. Freter, M. Lippman, E. Schiffman, and L. Liotta (1988) Autocrine motility factor AMF stimulates phosphatidylinositol turnover in human melanoma cells. Proc. Am. Assoc. Cancer Res. Ann. Meet. 29:65.Google Scholar
  40. 40.
    Kramer, R.H., K.G. Bensch, and J. Wong (1986) Invasion of reconstituted basement membrane matrix by metastatic human tumor cells. Cancer Res. 46:1980–1989.PubMedGoogle Scholar
  41. 41.
    Kramer, R.H., K.A. McDonald, E. Crowley, D.M. Ramos, and C Damsky (1989) Melanoma cell adhesion to basement membrane mediated by Integrin-related Complexes. Cancer Res. 49:393–402.PubMedGoogle Scholar
  42. 42.
    Leighton, J. (1964) Invasion, and metastasis of hetreologous tumors in the chick embryo. Prog. Exp. Tumor Res. 4:98–125.PubMedGoogle Scholar
  43. 43.
    Lester, B., J. McCarthy, Z. Sun, R. Smith, L. Furcht, and A. Spiegel (1989) Gprotein involvement in matrix-mediated motility and invasion of low experimental metastatic B16 melanoma clones. Cancer. Res. 49:5940–5948.PubMedGoogle Scholar
  44. 44.
    Liotta, LA. (1984) Tumor invasion and metastases: The role of basement membrane. Am. J. Pathol. 117:339–348.PubMedGoogle Scholar
  45. 45.
    Liotta, L.A. (1986) Tumor invasion and metastases: Role of the extracellular matrix: Rhoads memorial award lecture. Cancer Res. 46:1–7.PubMedCrossRefGoogle Scholar
  46. 46.
    Liotta, L.A., W.C. Lee, and D.J. Morakis (1980) New method for preparing large surfaces of intact basement membrane for tumor invasion studies. Cancer Lett 11:141–147.PubMedCrossRefGoogle Scholar
  47. 47.
    Liotta, L.A., R. Mandler, G. Murano, D.A. Katz, R.K. Gordon, P.K. Chiang, and E. Schiffman (1986) Tumor cell autocrine motility factor. Proc. Natl. Acad. Sci., USA 83:3302–3306.PubMedCrossRefGoogle Scholar
  48. 48.
    Liotta, L., P. Steeg, and W. Stetler-Stevenson (1991) Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 64:327–336.PubMedCrossRefGoogle Scholar
  49. 49.
    Liotta, L., U. Wewer, N. Rao, E. Schiffmann, M. Stracke, R. Guirguis, U. Thorgeirsson, R. Muschel, and M. Sobel (1988) Biochemical mechanisms of tumor invasion and metastases. Prog. Clin. Biol. Res. 256:3–16.PubMedGoogle Scholar
  50. 50.
    Mareel, M., G.K. DeBruyré, F. Vandesante, and C. Dragonetti (1981) Immunohistochemical study of embryonic chick heart invaded by malignant cells in three-dimensional culture. Invas. Metast. 1:195–204.Google Scholar
  51. 51.
    Martin, G.R., and R. Timpl (1987) Laminin and other basement membrane components. Ann. Rev. Cell Biol. 3:57–85.PubMedCrossRefGoogle Scholar
  52. 52.
    Maslow, D.E, and V.P. Terranova (1988) Modulation of cancer cell motility and invasiveness by epidermal and platelet-derived growth factors. Proc. Am. Assoc. Cancer Res. Ann. Meet. 29:67.Google Scholar
  53. 53.
    McGarvey, T., S. Siberman, and B. Persky (1990) The effect of butyric acid and retinoic acid on invasion and experimental metastasis of murine melanoma cells. Clin. Exp. Metastasis 8:433–448.PubMedCrossRefGoogle Scholar
  54. 54.
    Mecham, R.P. (1991) Receptors for laminin on mammalian cells. FASEB J. 5:2538–2546.PubMedGoogle Scholar
  55. 55.
    Meissauer, A., M. Kramer, M. Hofmann, L. Erkell, E. Jacob, V. Schirrmacher, and G. Brunner (1991) Urokinase-type and tissue-type plasminogen activators are essential for in vitro invasion of human melanoma cells. Exp. Cell Res. 192:453–459.PubMedCrossRefGoogle Scholar
  56. 56.
    Melchiori, A., S. Carlone, G. Allavena, O. Aresu, S. Parodi, S.A. Aaronson, and A. Albini (1990) Invasiveness and chemotactic activity of oncogene transformed NIH/3T3 cells. Anticancer Res. 10:37–44.PubMedGoogle Scholar
  57. 57.
    Melchiori, A., A. Colacci, P.L. Lollini, C. De Giovanni, S. Carlone, S. Grilli, S. Parodi, and A. Albini (1992) Induction of invasive and experimental metastasis potential in Balb/c3T3 cells by benzo(a)pyrene transformation. (Submitted for publication.)Google Scholar
  58. 58.
    Mensing, H., A. Albini, T. Krieg, B.F. Pontz, and P.K. Muller (1984) Enhanced chemotaxis of tumor-derived and virus-transformed cells to fibronectin and fibroblast conditioned medium. Int. J. Cancer 33:43–48.PubMedCrossRefGoogle Scholar
  59. 59.
    Mignatti, P., R. Tsuboi, E. Robbins, and D.B. Rifkin (1989) In vitro angiogenesis on the human amniotic membrane: Requirement for basic fibroblast growth factor-induced proteinases. J. Cell Biol. 108:671–682PubMedCrossRefGoogle Scholar
  60. 60.
    Moll, U., G. Youngleib, K. Rosinski, and J. Quigley (1990) Tumor promoter stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: Isolation and characterization of the enzyme from HT1080 tumor cells. Cancer Res. 50:6162–6170PubMedGoogle Scholar
  61. 61.
    Nakajima, M., D. Lotan, M.M. Baig, R.M. Carralero, W.R. Wood, M.J.C. Hendrix, and R. Lotan (1989) Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells. Cancer Res. 49:1698–1706.PubMedGoogle Scholar
  62. 62.
    Nicolson, G.L. (1982) Metastatic tumor cell attachment and invasion assay utilizing vascular endothelial cell monolayers. J. Histochem. Cvtoch. 30:214–220.CrossRefGoogle Scholar
  63. 63.
    Ossowski, S. (1988) In vivo invasion of modified chorioallantoic membrane by tumor cells: The role of cell surface-bound urokinase. J. Cell Biol. 197:2437–2445.CrossRefGoogle Scholar
  64. 64.
    Pourreau-Schneider, N., P. Delori, B. Boutiere, D. Arnoux, F. George, J. Sampol, and P.M. Martin (1989) Modulation of plasminogen activator systems by matrix components in two breast cancer cell lines MCF-7 and MDA-MB-231. J. Natl. Cancer Inst. 81:259–266.PubMedCrossRefGoogle Scholar
  65. 65.
    Reich, R., E.W. Thompson, Y. Iwamoto, G.M. Martin, J.R. Deason, G.C. Fuller, and R. Miskin (1988) Effects of inhibitors of plasminogen activator, serine protinases, and collagenase IV on the invasion of basement membranes by metastatic cells. Cancer Res. 48:3307–3312.PubMedGoogle Scholar
  66. 66.
    Repesh, L. (1989) A new in vitro assay for quantitating tumor cell invasion. Invasion-Metastasis 9:192–208.PubMedGoogle Scholar
  67. 67.
    Rochefort, H., P. Augereau, P. Briozzo, F. Capony, V. Cavailles, G. Freiss, M. Garcia, T. Maudelonde, M. Morisset, and F. Vignon (1988) Structure, function, regulation and clinical significance of the 52K pro-cathepsin D secreted by breast cancer cells. Biochimie 70:943–949.PubMedCrossRefGoogle Scholar
  68. 68.
    Ruoslahti, E., and M.D. Pierschbacher (1987) New perspectives in cell adhesion: RGD and integrins. Science 38:491–497.CrossRefGoogle Scholar
  69. 69.
    Saiki, I., J. Murata, T. Makabe, Y. Matsumoto, Y. Ohdate, Y. Kawase, Y. Taguchi, T. Shimojo, F. Kimizuka, and I. Kato (1990) Inhibition of lung metastasis by synthetic and recombinant fragments of human fibronectin with functional domains. Jpn. J. Cancer Res. 81:1003–1011.PubMedGoogle Scholar
  70. 70.
    Saiki, I., J. Murata, K. Watanabe, H. Fujii, F. Abe, and I. Azuma (1989) Inhibition of tumor cell invasion by ubenimex (bestatin) in vitro. Jpn. J. Cancer Res. 80:873–878.PubMedCrossRefGoogle Scholar
  71. 71.
    Sasaki, M., H.K. Kleinman, H. Huber, R. Deutzmann, and Y. Yamada (1988) Laminin, a multidomain protein. The A chain has a unique globular domain and homology with the basement membrane proteoglycan and the laminin B chains. J. Biol. Chem. 263:16536–16544.PubMedGoogle Scholar
  72. 72.
    Scher, C.D., C. Haudenschild, and M. Klagsbrun (1976) The chick chorioallantoic membrane as a model system for the study of tissue invasion by viral transformed cells. Cell 8:373–382.PubMedCrossRefGoogle Scholar
  73. 73.
    Schlechte, W., M. Brattain, and D. Boyd (1990) Invasion of extracellular matrix by cultured colon cancer cells: Dependence on urokinase receptor display. Cancer Comm. 2:173–179.Google Scholar
  74. 74.
    Shultz, R.M., S. Silberman, B. Persky, A.S. Bajowski, and D.F. Carmichael (1988) Inhibition of human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. Cancer Res. 48:5539–5545.Google Scholar
  75. 75.
    Sloane, B.F., K. Moin, E. Kzepela, and J. Rozhin (1990) Cathepsin B and its enogenous inhibitors: The role in tumor malignancy. Cancer Metastasis Rev. 9:333–352.PubMedCrossRefGoogle Scholar
  76. 76.
    Starkey, J.R., H.L. Hosick, D.R. Stanford, and H.D. Liggett (1984) Interaction of metastatic tumor cells with bovine lens capsule basement membrane. Cancer Res. 44:1585–1594.PubMedGoogle Scholar
  77. 77.
    Stetler-Stevenson, W.G., J. Talano, M. Gallagher, H.C. Krutzsch, and L.A. Liotta (1991) Inhibition of human type IV collagenase by a highly conserved peptide sequence derived from its prosegment. American J. Medic. Scien. 302:163–170.CrossRefGoogle Scholar
  78. 78.
    Stetler-Stevenson, W.G. (1990) Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev. 9:289–303.PubMedCrossRefGoogle Scholar
  79. 79.
    Stetler-Stevenson, W.G., H. Krutzsch, and L.A. Liotta (1989) Tissue inhibitor of metalloproteinase-2 (TIMP-2): A new member of the metalloproteinase inhibitor family. J. Biol. Chem. 264:17374–17378.PubMedGoogle Scholar
  80. 80.
    Stetler-Stevenson, W.G., H. Krutzsch, M. Wacher, M.K. Margulies, and L.A. Liotta (1989) The activation of human type IV collagenase proenzyme. J. Biol. Chem. 264:1353–1356.PubMedGoogle Scholar
  81. 81.
    Stracke, M.L., E. Kohn, S. Aznavoorian, L. Wilson, D. Salomon, H. Krutzsch, L.A. Liotta, and E. Schiffmann (1988) Insulin-like growth factors stimulate chemotaxis in human melanoma cells. Biochem. Biophvs. Res. Comm. 153:1076–1083.CrossRefGoogle Scholar
  82. 82.
    Terranova, P., E.S. Hujanen, and G.R. Martin (1986) Basement membranes and the invasive activity of metastatic tumor cells. J. Natl. Cancer Inst. 77:311–316.PubMedGoogle Scholar
  83. 83.
    Terranova, V.P., E.S. Hujanen, D.M. Loeb, G.R. Martin, L. Thornburg, and V. Glushko (1986) Use of a reconstituted basement membrane to measure cell invasiveness and select for highly invasive tumor cells. Proc. Natl. Acad. Sci., USA 83:465–469.PubMedCrossRefGoogle Scholar
  84. 84.
    Terranova, V.P., L.A. Liotta, R.G. Russo, and G.R. Martin (1982) Role of laminin in the attachment and metastasis of murine tumor cells. Cancer Res. 42:2265–2269.PubMedGoogle Scholar
  85. 85.
    Terranova, V.P., C.N. Rao, T. Kalebic, I.M. Margulies, and L.A. Liotta (1983) Laminin receptors on human breast carcinoma cells. Proc. Natl. Acad. Sci., USA 80:444–448.PubMedCrossRefGoogle Scholar
  86. 86.
    Terranova, V.P., J.E. Williams, L.A. Liotta, and G.R. Martin (1984) Modulation of the metastatic activity of melanoma cells by laminin and fibronectin. Science 226:982–984.PubMedCrossRefGoogle Scholar
  87. 87.
    Testa, J.E., and J.O. Quigley (1990) The role of urokinase-type plasminogen activator in aggressive tumor cell behaviour. Cancer Metastasis Rev. 9:353–367.PubMedCrossRefGoogle Scholar
  88. 88.
    Thompson, E., S. Nakamura, T. Shima, A. Melchiori, G. Martin, S. Salahuddin, R. Gallo, and A. Albini (1991) Supernatants of acquired immunodeficiency syndrome-related Kaposi’s sarcoma cells induce endothelial cell chemotaxis and invasiveness. Cancer Res. 51:2670–2671.PubMedGoogle Scholar
  89. 89.
    Turpeenniemi-Hujianen, T., U.P. Thorgeirrson, C.N. Rao, and L.A. Liotta (1986) Laminin increases the release of type IV collagenase from malignant cells. L Biol. Chem. 261:1883–1889.Google Scholar
  90. 90.
    Van Wart, H.E, and H. Birkedal-Hansen (1990) The cysteine switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl. Acad. Sci., USA 87:5578–5582.PubMedCrossRefGoogle Scholar
  91. 91.
    Varani, J., and P.A. Ward (1982) Tumor cell chemotaxis. In The biological basis of metastasis, I. Hart and L.A. Liotta, eds. Martinus Nijhoff, The Hague, pp. 99–112.Google Scholar
  92. 92.
    Welch, D.A., T.J. Lobl, E.A. Seftor, P.J. Wack, P.A. Aeed, K.H. Yohem, R.E.B. Seftor, and M.J.C. Hendrix (1989) Use of the membrane invasion culture system (MICS) as a screen for anti-invasive agents. Int. J. Cancer 43:449–457.PubMedCrossRefGoogle Scholar
  93. 93.
    Xu, H., J. Sumegi, S.X. Hu, A. Namerjee, A., E. Uzvolgyi, and W.F. Benedict (1990) Intraocular tumor formation of RB reconstituted retinoblastoma cells.62. Cancer Res. 51:4481–4485.Google Scholar
  94. 94.
    Yagel, S., R.S. Parher, J.J. Jeffrey, and P.K. Lala (1988) Normal nonmetastatic human trophoblast cells share in vitro invasive properties of malignant cells. J. Cell Phvsiol. 136:455–462.CrossRefGoogle Scholar
  95. 95.
    Yamada, K., D. Kennedy, S. Yamada, H. Gralnick, W. Chen, and S. Akiyama (1990) Monoclonal antibody and synthetic peptide inhibitors of human tumor cell migration. Cancer Res. 50:4485–4496.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1993

Authors and Affiliations

  • Adriana Albini
    • 1
    • 2
  • Annamaria Colacci
    • 1
    • 2
  1. 1.Istituto Nazionale per la Ricerca sul CancroGenovaItaly
  2. 2.Biotechnology Satellite UnitIstituto Nazionale per la Ricerca sul CancroBolognaItaly

Personalised recommendations